Tag:
Big Pharma
Latest Headlines
Latest Headlines
Three new rules for biopharma collaborations
Last week Ryan McBride moderated a panel called "The New Rules of Partnerships and Collaborations" at the Convergence East conference on Cape Cod, and the experience yielded a chance to probe some of the biopharma industry's top dealmakers about their preferences and prejudices going into talks with other companies.
Startup Knode takes off with pharma fuel
Knode has sprung to life with web-based software to enable life sciences stakeholders to hunt for top experts.
UPDATED: Mobile apps could rival pharma's crown jewels
As we pack more data about our health into mobile devices, pharma companies could face a new competitive threat to their drugs: Mobile health apps.
Big Pharma's high-risk pursuit of CNS gold faces major market doubts
Here's an interesting number for anyone interested in the risks and rewards of drug development: Two of every three analysts and fund managers recently queried by the ISI Group say they expect that new Alzheimer's drugs in late-stage testing at Eli Lilly and Pfizer/J&J will fail.
Burrill: Big Pharma's academic tie-ups are 'nuts'
Biotech visionary Steven Burrill discussed Big Pharma's role in the healthcare system and mentioned that its fate will lie in its ability to reinvent itself.
Indian panel accuses Big Pharma of colluding with regulators
An Indian government report has hit the domestic pharma business like a whirlwind--and sucked Big Pharma into the fury.
Pharma's biotech buyouts stymied by price
Biotech shareholders don't want to sell at bargain prices. Pharma doesn't want to pay big premiums. Who's going to prevail?
Crazy or creative? MIT finance whiz suggests a twist on CDOs for R&D
MIT finance engineering professor Andrew Lo caused a stir this week when he expounded on an unorthodox idea.
Scrambling to add new drugs, Big Pharma is paying big premiums for biotechs
If you've been thinking that it's a seller's market out there for biotech companies, Bloomberg has some numbers to support the case.
Flexibility, understanding key for CRO and pharma trust, study says
A report authored by Booz & Co. and Irish CRO Icon looks at how CROs and big pharma companies can improve working relations...
